Clinical Trials Browser

Phase 4 × Refractory Solid Tumors × Sunitinib × Clear all

NCT02691793 2022-06-15

Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors

Phase 4 Completed

Other solid neoplasm

Refractory Solid Tumors